1/3/13 21:32 | 1/1/13 | NGSX | Health | Drug | Pharmaceutical Preparations | Martell Ron | CA | O | P,CEO | M.d | 0 | 0.00 | 0 | 25 | New | 25 | D | | | | | | | | | | | | | | |
12/4/12 16:23 | 12/1/12 | NGSX | Health | Drug | Pharmaceutical Preparations | Ghiglieri Stephen F | CA | O | Exec. VP | M.d | 0 | 0.00 | 0 | 4 | 5 | 86 | D | | | | | | | | | | | | | | |
11/14/12 15:45 | 11/9/12 | NGSX | Health | Drug | Pharmaceutical Preparations | Peroutka Stephen J | CA | O | VP,CMO | M.d | 0 | 0.00 | 0 | 19 | New | 19 | D | | | | | | | | | | | | | | |
9/1/11 13:37 | 7/26/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Nelsen Robert | IL | DT | | P.a | 2,878 | 1.65 | 0 | 1,744 | 71 | 4,188 | I | -73 | -67 | -44 | -16 | 20 | -4 | 16 | 14 | -12 | -13 | -55 | -54 | -70 | |
8/12/11 06:04 | 8/9/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S.m | -340 | 2.08 | 0 | -163 | -100 | 0 | I | -72 | -66 | -59 | -28 | 18 | 23 | -12 | -13 | -5 | -15 | -20 | -39 | -72 | |
8/11/11 10:38 | 8/9/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -340 | 2.08 | 0 | -163 | -100 | 0 | I | -77 | -71 | -65 | -40 | -2 | 6 | -24 | -26 | 17 | 2 | -6 | -27 | -54 | |
7/26/11 20:54 | 7/26/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Nelsen Robert | IL | DT | | P.d | 2,878 | 1.65 | 0 | 1,744 | 71 | 4,188 | I | -80 | -76 | -71 | -50 | 8 | 7 | 4 | 5 | 12 | 31 | -3 | -41 | -49 | |
7/25/11 21:09 | 7/21/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund V LP | IL | T | | P.d | 2,878 | 1.65 | 0 | 1,744 | 71 | 4,188 | D | -79 | -76 | -72 | -49 | -5 | -2 | -4 | 1 | 0 | 38 | -3 | -46 | -49 | |
6/28/11 08:54 | 6/24/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -18 | 2.10 | 1 | -9 | -5 | 163 | I | -67 | -72 | -70 | -49 | -28 | -4 | -22 | 14 | -4 | -17 | -1 | -25 | -50 | |
6/28/11 08:50 | 6/24/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S.m | -18 | 2.10 | 1 | -9 | -5 | 163 | I | -67 | -72 | -70 | -49 | -28 | -4 | -22 | 14 | -4 | -17 | -1 | -25 | -50 | |
6/27/11 08:35 | 6/23/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S | -105 | 2.09 | 1 | -50 | -23 | 172 | I | -64 | -72 | -71 | -51 | -29 | -5 | -26 | 13 | 0 | -14 | -12 | -21 | -54 | |
6/27/11 08:33 | 6/23/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -105 | 2.09 | 1 | -50 | -23 | 172 | I | -64 | -72 | -71 | -51 | -29 | -5 | -26 | 13 | 0 | -14 | -12 | -21 | -54 | |
6/23/11 13:07 | 6/16/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.a | -1,253 | 3.14 | 0 | -399 | -51 | 385 | I | -70 | -78 | -75 | -56 | -41 | -26 | 7 | -16 | 18 | 3 | -3 | -4 | -49 | |
6/20/11 08:38 | 6/16/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S | -961 | 3.20 | 0 | -300 | -57 | 222 | I | -69 | -75 | -69 | -40 | -32 | -19 | 4 | 28 | -9 | -4 | -20 | -23 | -52 | |
6/20/11 07:57 | 6/16/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -1,253 | 3.14 | 0 | -399 | -61 | 255 | I | -69 | -75 | -69 | -40 | -32 | -19 | 4 | 28 | -9 | -4 | -20 | -23 | -52 | |
6/6/11 08:19 | 6/2/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -49 | 2.34 | 0 | -21 | -7 | 262 | I | -64 | -70 | -61 | -40 | -33 | -21 | -11 | -15 | -5 | -20 | -25 | -21 | -54 | |
6/2/11 09:52 | 6/1/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -27 | 2.46 | 0 | -11 | -4 | 283 | I | -60 | -69 | -55 | -29 | -24 | -18 | -10 | -7 | -2 | -17 | -27 | -26 | -60 | |
5/19/11 16:19 | 5/17/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | EVP Rese | S.m | -7 | 2.77 | 0 | -2 | -33 | 5 | D | -41 | -66 | -53 | -36 | -26 | -17 | -5 | 2 | -6 | -10 | -26 | -37 | -62 | |
5/16/11 21:05 | 5/12/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | EVP Rese | S.m | -8 | 2.85 | 0 | -3 | -26 | 7 | D | -33 | -70 | -58 | -44 | -29 | -20 | -8 | -9 | 1 | -4 | -41 | -29 | -58 | |
5/10/11 19:24 | 5/6/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Ghiglieri Stephen F | CA | O | EVP,COO, | P | 18 | 3.03 | 0 | 6 | 19 | 38 | I | 5 | -69 | -57 | -41 | -23 | -3 | -13 | -2 | -4 | -10 | -36 | -23 | -68 | |
3/30/11 09:50 | 3/28/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -50 | 4.07 | 0 | -12 | -4 | 294 | I | 22 | -60 | -42 | -40 | -20 | 2 | 10 | -5 | 5 | 2 | -10 | -50 | -69 | |
3/28/11 12:05 | 3/24/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -616 | 4.03 | 0 | -153 | -23 | 522 | I | 18 | -56 | -39 | -42 | -20 | 7 | 26 | 7 | -3 | -3 | -14 | -51 | -61 | |
3/28/11 12:03 | 3/24/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S.m | -616 | 4.03 | 0 | -153 | -23 | 522 | I | 18 | -56 | -39 | -42 | -20 | 7 | 26 | 7 | -3 | -3 | -14 | -51 | -61 | |
3/25/11 18:03 | 3/23/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S | -135 | 4.01 | 0 | -34 | -3 | 981 | I | 24 | -58 | -39 | -42 | -20 | 9 | 19 | 8 | -3 | 0 | -13 | -50 | -61 | |
3/25/11 18:01 | 3/23/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | S | -49 | 4.01 | 0 | -12 | -2 | 675 | I | 24 | -58 | -39 | -42 | -20 | 9 | 19 | 8 | -3 | 0 | -13 | -50 | -61 | |
3/2/11 11:26 | 2/28/11 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -52 | 3.67 | 0 | -14 | -4 | 328 | I | 194 | -55 | -40 | -39 | -41 | -31 | -16 | -10 | -3 | 4 | 15 | -26 | -47 | -83 |
9/13/10 11:30 | 9/9/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | P | 165 | 5.50 | 0 | 30 | 1 | 2,648 | D | 77 | -28 | -28 | -27 | -22 | -1 | -4 | -4 | 6 | 15 | 23 | 10 | -36 | -70 |
8/20/10 15:22 | 8/19/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Markels Michael | CA | O | SVP,Comm | P | 14 | 5.75 | 0 | 3 | 13 | 22 | D | 79 | -19 | -26 | -27 | -23 | -19 | -5 | -6 | -2 | 3 | 20 | 5 | -28 | -69 |
8/11/10 13:47 | 8/10/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Goodwin Bradford S | CA | D | | P | 30 | 6.03 | 0 | 5 | 50 | 15 | D | 91 | -23 | -18 | -41 | -9 | -9 | -16 | -12 | 0 | 1 | -8 | 14 | -17 | -66 |
7/29/10 11:23 | 12/3/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | P.m | 1,622 | 7.77 | 0 | 209 | 25 | 1,029 | I | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
7/29/10 11:20 | 11/11/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | S.m | -220 | 8.32 | 0 | -26 | -3 | 820 | I | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
7/29/10 11:20 | 9/11/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Breen Doron | L3 | H | member o | P.m | 3,621 | 8.34 | 0 | 434 | 113 | 820 | I | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
7/29/10 11:12 | 1/25/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | P.m | 1,172 | 7.23 | 0 | 162 | 5 | 3,305 | M | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
7/29/10 11:09 | 9/11/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Arkin Moshe | L3 | TH | also mem | P.m | 11,440 | 7.92 | 0 | 1,445 | 85 | 3,143 | M | 108 | -16 | 2 | -27 | -12 | -1 | 11 | 3 | -3 | -3 | -19 | 2 | -19 | -73 |
6/9/10 15:08 | 6/7/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Goodwin Bradford S | CA | D | | P.m | 73 | 7.27 | 0 | 10 | New | 10 | D | 130 | 14 | -10 | -12 | -27 | -20 | -12 | -9 | 0 | 16 | 4 | -17 | -19 | -71 |
5/26/10 13:19 | 5/24/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | S | -16 | 8.07 | 1 | -2 | -17 | 10 | D | 116 | 29 | -9 | -2 | -19 | -23 | -19 | -2 | -1 | 1 | 0 | -26 | -24 | -68 |
5/21/10 13:14 | 5/19/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | S | -13 | 8.71 | 1 | -2 | -11 | 12 | D | 121 | 47 | -11 | 2 | -15 | -22 | -23 | -15 | 2 | 2 | -2 | -27 | -23 | -64 |
5/5/10 15:56 | 5/3/10 | NGSX | Health | Drug | Pharmaceutical Preparations | Svlsf Iv, LLC | MA | T | | S | -3,075 | 10.25 | 1 | -300 | -83 | 61 | D | 230 | 242 | 26 | 37 | 18 | 4 | 9 | -1 | 1 | 2 | -22 | -31 | -30 | -68 |
12/1/09 18:53 | 11/30/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | Chief Me | S.d | -97 | 8.07 | 1 | -12 | -64 | 7 | D | 15 | 628 | 34 | 8 | 0 | 3 | -6 | -5 | 4 | -9 | -4 | -4 | -4 | -34 |
12/1/09 18:53 | 11/30/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | Chief Me | M.d | 15 | 1.25 | 1 | 12 | | 7 | D | 15 | 628 | 34 | 8 | 0 | 3 | -6 | -5 | 4 | -9 | -4 | -4 | -4 | -34 |
11/30/09 20:38 | 11/25/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | Chief Me | S.dm | -83 | 8.38 | 1 | -10 | -60 | 7 | D | 15 | 571 | 41 | 6 | -1 | 11 | -9 | -6 | 1 | -3 | -5 | -5 | -7 | -29 |
11/30/09 20:38 | 11/25/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Tobias Jeffrey K | CA | O | Chief Me | M.dm | 12 | 1.25 | 1 | 10 | | 7 | D | 15 | 571 | 41 | 6 | -1 | 11 | -9 | -6 | 1 | -3 | -5 | -5 | -7 | -29 |
11/23/09 13:33 | 11/19/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | S.m | -50 | 8.28 | 1 | -6 | -31 | 14 | D | 38 | 445 | 42 | 17 | 3 | 7 | 2 | -4 | 1 | -5 | -12 | -7 | -9 | -31 |
9/17/09 16:19 | 9/15/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Svlsf Iv, LLC | MA | T | | S | -14,760 | 8.00 | 1 | -1,845 | -42 | 2,591 | S | | | | | | | | | -1 | -1 | -2 | -11 | 1 | -23 |
8/21/09 19:19 | 8/20/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | S | -7 | 7.22 | 1 | -1 | -5 | 20 | D | 5 | 127 | 437 | 52 | 21 | -8 | -5 | 0 | 0 | 5 | 11 | 18 | 7 | -22 |
8/17/09 19:36 | 8/14/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | S.m | -49 | 7.25 | 1 | -7 | -25 | 21 | D | 6 | 134 | 416 | 52 | 25 | -17 | -8 | -4 | -1 | 0 | 15 | 13 | 3 | -16 |
8/14/09 16:00 | 8/12/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | S.m | -42 | 7.39 | 1 | -6 | -17 | 27 | D | 4 | 137 | 383 | 74 | 24 | -18 | -9 | -7 | 0 | 0 | 6 | 14 | 1 | -20 |
7/15/09 16:30 | 7/13/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S | -1,493 | 5.97 | 1 | -250 | -14 | 1,526 | I | -19 | 89 | 395 | 168 | 8 | 10 | 10 | 8 | 2 | 15 | 11 | 23 | 8 | 10 |
7/10/09 17:23 | 7/8/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S.m | -140 | 5.92 | 1 | -24 | -1 | 1,776 | I | -27 | 83 | 301 | 142 | 8 | -11 | 0 | 2 | -1 | 13 | 30 | 33 | 20 | 23 |
7/8/09 17:27 | 7/6/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S.m | -323 | 5.93 | 1 | -54 | -3 | 1,799 | I | -28 | 82 | 348 | 117 | -2 | -10 | 7 | -1 | -1 | 8 | 34 | 34 | 24 | 20 |
7/1/09 18:19 | 6/26/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S.m | -1,615 | 5.87 | 1 | -275 | -13 | 1,854 | I | -34 | 87 | 289 | 82 | 18 | -9 | -15 | 3 | 0 | 2 | 50 | 41 | 31 | 14 |
6/25/09 10:01 | 6/22/09 | NGSX | Health | Drug | Pharmaceutical Preparations | Flynn James E | NY | TH | Possible | S.m | -520 | 6.24 | 0 | -83 | -4 | 2,129 | I | -29 | 85 | 317 | 79 | 54 | -4 | -8 | -13 | -6 | 1 | 53 | 41 | 28 | 32 |
12/12/08 15:11 | 12/10/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | P | 0 | 1.67 | 0 | 0 | 1 | 33 | D | | -75 | -45 | -46 | 10 | 4 | 1 | -10 | -8 | -1 | -14 | 2 | 291 | 381 |
12/11/08 13:48 | 12/9/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Markels Michael | CA | O | VP,Comme | P | 0 | 1.50 | 0 | 0 | 1 | 16 | D | | -75 | -46 | -44 | 6 | 11 | 20 | -5 | -4 | -17 | -22 | -2 | 286 | 366 |
12/11/08 13:48 | 12/10/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Ghiglieri Stephen F | CA | O | CFO | P | 1 | 1.67 | 0 | 1 | 1 | 38 | D | | -75 | -46 | -44 | 6 | 11 | 20 | -5 | -4 | -17 | -22 | -2 | 286 | 366 |
12/9/08 17:32 | 12/5/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | P.m | 6 | 1.74 | 0 | 3 | 12 | 33 | D | | -75 | -45 | -43 | 27 | 31 | 48 | 11 | -7 | -14 | -25 | -34 | 246 | 320 |
12/8/08 18:03 | 12/4/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Markels Michael | CA | O | VP,Comme | P.m | 3 | 1.66 | 0 | 2 | 15 | 16 | D | | -71 | -41 | -43 | 6 | -7 | 47 | 10 | 1 | -17 | -17 | -39 | 237 | 320 |
12/3/08 18:38 | 12/1/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | P.m | 2 | 1.27 | 0 | 2 | 6 | 29 | D | | -76 | -57 | -47 | -10 | 25 | 3 | 33 | -7 | 11 | -29 | -32 | 277 | 425 |
12/3/08 16:19 | 12/1/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Ghiglieri Stephen F | CA | O | CFO | P.m | 4 | 1.47 | 0 | 3 | 8 | 38 | D | | -76 | -57 | -47 | -10 | 25 | 3 | 33 | -7 | 11 | -29 | -32 | 277 | 425 |
11/25/08 14:51 | 11/21/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Markels Michael | CA | O | VP,Comme | P | 3 | 1.51 | 0 | 2 | 14 | 14 | D | | -81 | -64 | -62 | -8 | -31 | -25 | -20 | 0 | 33 | 27 | 18 | 359 | 601 |
11/25/08 14:51 | 11/21/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Ghiglieri Stephen F | CA | O | CFO | P | 3 | 1.60 | 0 | 2 | 6 | 35 | D | | -81 | -64 | -62 | -8 | -31 | -25 | -20 | 0 | 33 | 27 | 18 | 359 | 601 |
11/20/08 17:34 | 11/18/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Ghiglieri Stephen F | CA | O | CFO | P.m | 5 | 1.62 | 0 | 3 | 10 | 33 | D | | -76 | -58 | -51 | 6 | 2 | -14 | -21 | -8 | -23 | -16 | -15 | 235 | 455 |
11/20/08 16:29 | 11/18/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Markels Michael | CA | O | VP,Comme | P.m | 3 | 1.50 | 0 | 2 | 17 | 12 | D | | -76 | -58 | -51 | 6 | 2 | -14 | -21 | -8 | -23 | -16 | -15 | 235 | 455 |
11/14/08 17:14 | 11/12/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Markels Michael | CA | O | VP,Busin | P.m | 5 | 1.65 | 0 | 3 | 56 | 9 | D | | -76 | -51 | -47 | -19 | -3 | -8 | -8 | -28 | -22 | -22 | -25 | 176 | 396 |
5/22/08 17:52 | 5/20/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | P.m | 42 | 3.52 | 0 | 12 | 76 | 28 | D | | -54 | -45 | -44 | -1 | 23 | 14 | 9 | -1 | -6 | -15 | -11 | -50 | 33 |
5/14/08 16:12 | 5/13/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Ghiglieri Stephen F | CA | O | CFO | M.d | 22 | 1.80 | 0 | 12 | 78 | 27 | D | | -65 | -58 | -48 | -20 | -7 | 3 | -4 | -2 | 10 | -5 | -8 | -48 | 16 |
4/22/08 15:25 | 4/21/08 | NGSX | Health | Drug | Pharmaceutical Preparations | Ditonno Anthony A | CA | DO | P,CEO,Di | M.d | 59 | 2.70 | 0 | 22 | 26 | 106 | D | | | -57 | -34 | 22 | -5 | 2 | 6 | -4 | -15 | -3 | -8 | -66 | -36 |
1/3/08 15:50 | 12/31/07 | NGSX | Health | Drug | Pharmaceutical Preparations | Ghiglieri Stephen F | CA | O | CFO | M.d | 14 | 1.80 | 0 | 8 | 108 | 15 | D | | | -23 | -24 | 1 | -1 | 7 | 8 | 3 | -17 | -8 | -43 | -50 | -82 |
12/27/07 16:30 | 12/24/07 | NGSX | Health | Drug | Pharmaceutical Preparations | Arch Venture Partners V LP | IL | T | | P.d | 2,362 | 6.18 | 0 | 382 | 19 | 2,444 | D | | | -30 | -28 | -14 | -1 | 3 | 0 | -1 | 11 | -5 | -38 | -51 | -74 |
11/21/07 15:32 | 11/19/07 | NGSX | Health | Drug | Pharmaceutical Preparations | Markels Michael | CA | O | VP,Busin | P.m | 19 | 6.45 | 0 | 3 | 225 | 4 | D | | | -17 | -10 | -29 | -26 | -15 | -10 | -2 | 13 | -1 | 0 | -42 | -76 |
9/11/07 11:33 | 9/10/07 | NGSX | Health | Drug | Pharmaceutical Preparations | Bienaime Jean Jacques | CA | D | | P | 17 | 8.68 | 0 | 2 | 14 | 16 | D | | | | 10 | 28 | 25 | 29 | 13 | 3 | 7 | 0 | -18 | -65 | -64 |
5/4/07 17:04 | 5/2/07 | NGSX | Health | Drug | Pharmaceutical Preparations | Arch Venture Fund V LP | IL | T | | P | 2,497 | 11.00 | 9 | 227 | New | 227 | D | | | | | | | | | -1 | -20 | -25 | -33 | -20 | -71 |
5/4/07 16:51 | 5/2/07 | NGSX | Health | Drug | Pharmaceutical Preparations | Nelsen Robert | IL | DT | | P | 2,497 | 11.00 | 9 | 227 | New | 227 | I | | | | | | | | | -1 | -20 | -25 | -33 | -20 | -71 |